- Home
- PCB vs FDMT Comparison
PCB vs FDMT Comparison
Compare PCB & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCB
- FDMT
- Stock Information
- Founded
- PCB 2003
- FDMT 2013
- Country
- PCB United States
- FDMT United States
- Employees
- PCB N/A
- FDMT N/A
- Industry
- PCB Major Banks
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- PCB Finance
- FDMT Health Care
- Exchange
- PCB Nasdaq
- FDMT Nasdaq
- Market Cap
- PCB 264.4M
- FDMT 268.6M
- IPO Year
- PCB N/A
- FDMT 2020
- Fundamental
- Price
- PCB $19.47
- FDMT $4.58
- Analyst Decision
- PCB Hold
- FDMT Buy
- Analyst Count
- PCB 2
- FDMT 11
- Target Price
- PCB $22.00
- FDMT $41.70
- AVG Volume (30 Days)
- PCB 24.0K
- FDMT 1.1M
- Earning Date
- PCB 01-31-2025
- FDMT 02-27-2025
- Dividend Yield
- PCB 3.70%
- FDMT N/A
- EPS Growth
- PCB N/A
- FDMT N/A
- EPS
- PCB 1.68
- FDMT N/A
- Revenue
- PCB $94,833,000.00
- FDMT $17,000.00
- Revenue This Year
- PCB N/A
- FDMT N/A
- Revenue Next Year
- PCB $10.40
- FDMT $159.49
- P/E Ratio
- PCB $11.59
- FDMT N/A
- Revenue Growth
- PCB N/A
- FDMT N/A
- 52 Week Low
- PCB $14.50
- FDMT $4.50
- 52 Week High
- PCB $22.20
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- PCB 44.81
- FDMT 30.88
- Support Level
- PCB $18.14
- FDMT $4.68
- Resistance Level
- PCB $19.85
- FDMT $5.15
- Average True Range (ATR)
- PCB 0.56
- FDMT 0.43
- MACD
- PCB -0.00
- FDMT -0.05
- Stochastic Oscillator
- PCB 56.84
- FDMT 3.69
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.